carbamoylmethyl

5-Carbamoylmethyl uridine is a Nucleoside Derivative - 5-Modified pyrimidine nucleoside; Naturally modified Ribo-nucleoside.

Repaglinide (AG-EE 623ZW) is a benzoic acid derivative that stimulates insulin secretion from the pancreas and is used in the therapy of type 2 diabetes. Repaglinide has been linked to rare instances of clinically apparent acute liver injury.

2-[(2S,5S)-5-(carbamoylmethyl)-3,6-dioxopiperazin-2-yl]acetamide is a compound used as a molecular structural unit, a cyclic dipeptide. It induces apoptosis, inhibits cell proliferation and modulates immune responses, and possesses a wide range of biological activities including antitumor, antifungal, antibacterial, antiviral and immune-conditioning activities.

'3'-Hydroxy Repaglinide, a primary CYP2C8 metabolite of Repaglinide, is derived from carbamoylmethyl benzoic acid and is used in the treatment of type II diabetes.